雌孕激素替代疗法曾风靡一时,在美国等发达国家近几年来,许多医生把雌孕激素疗法作为一种希望疗法广泛地用于冠心病、结肠癌等常见及高发病症的治疗上,然而,对于HRT疗法学术界的分歧非常大。 在一切悬而未决的时候,第一个大样本关于绝经后妇女使用激素的随机、双盲、对照的一级预防试验WHI研究结果震惊全球,《中国处方药》特别邀请了长期关注和研究雌孕激素疗法的杨欣教授对这一研究结果进行分析解读,并通过一些国外的医生对这一疗 Estrogen and progesterone replacement therapy was all the rage in the United States and other developed countries in recent years, many doctors estrogen and progesterone therapy as a hope therapy widely used in coronary heart disease, colon cancer and other common and high incidence of treatment, however, The disagreement for HRT therapy academia is very large. The first large sample of the first large randomized, double-blind, controlled primary prevention trial in postmenopausal women to use hormones shocked the world at WHI, and the Chinese Prescription Drug specifically invited long-term attention and research into estrogen and progestogen therapies Professor Yang Xin analysis of the results of this study, and through some foreign doctors on the treatment